Cargando…
Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Immunohistochemistry has become an essential ancillary examination for the identification and classification of carcinomas of unknown primary site (CUPs). Over the last decade, the diagnostic accuracy of organ- or tumour-specific immunomarkers and the clinical validation of effective immunohistochem...
Autores principales: | Selves, Janick, Long-Mira, Elodie, Mathieu, Marie-Christine, Rochaix, Philippe, Ilié, Marius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923363/ https://www.ncbi.nlm.nih.gov/pubmed/29621151 http://dx.doi.org/10.3390/cancers10040108 |
Ejemplares similares
-
Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018) -
Occult Breast Cancer Presenting as Metastatic Adenocarcinoma of Unknown Primary: Clinical Presentation, Immunohistochemistry, and Molecular Analysis
por: Wang, Jue, et al.
Publicado: (2012) -
Metastatic Gastrointestinal Carcinoid Tumor with Unknown Primary Site
por: Liang, Peter S., et al.
Publicado: (2015) -
Metastatic angiosarcoma of unknown primary site misdiagnosed as tuberculosis
por: Issakwisa, Mwakyula, et al.
Publicado: (2020) -
Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
por: Hofman, Paul, et al.
Publicado: (2019)